Sun Pharma Baska facility gets OAI status from USFDA

Mumbai:  Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and Drug Administration (USFDA) for Baska facility.

The USFDA conducted an inspection at the facility from 8 September 2025 to 19 September 2025.

OAI means regulatory and/or administrative actions are recommended.

“We continue to manufacture and supply approved products from the facility to the US market. We will work with the regulator to achieve fully compliant status,” the company stated in a BSE filing.

Sun Pharma is a specialty generics company with a presence in specialty, generics and consumer healthcare products. Sun Pharma’s global specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. Its manufacturing facilities are spread across six continents.

Related Posts

Pvt nursing home sealed in Chatra after woman, unborn baby die

Chatra: The Chatra administration on Sunday sealed a private nursing home operating near Chatra bus stand following the death of a 20-year-old pregnant woman and her unborn child. The deceased…

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Thirty doctors who were found guilty of accepting a foreign trip worth Rs 2 crore to Paris and Monaco, funded by a pharma company, come from at least nine states.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Drug companies directed to step up vigil on adverse reactions

Drug companies directed to step up vigil on adverse reactions

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities

AI-designed universal coronavirus vaccine passes first human trial

AI-designed universal coronavirus vaccine passes first human trial